Watchlist Price Alert

Autolus Therapeutics (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

2.35

0.09 (3.98%)

At close: Jun 06, 2025, 3:59 PM

2.35

0.21%

After-hours: Jun 06, 2025, 05:43 PM EDT

3.98% (1D)

Bid	2.35
Market Cap	624.09M
Revenue (ttm)	9.01M
Net Income (ttm)	-238.13M
EPS (ttm)	-0.88
PE Ratio (ttm)	-2.66
Forward PE	-3.02
Analyst	Buy

Ask	2.39
Volume	2,548,587
Avg. Volume (20D)	2,080,198
Open	2.29
Previous Close	2.26
Day's Range	2.28 - 2.43
52-Week Range	1.10 - 5.00
Beta	1.74

About AUTL

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol AUTL

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AUTL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

4 weeks ago

+9.76%

Autolus Therapeutics shares are trading higher fol... Unlock content with Pro Subscription

2 months ago

-9.03%

Autolus Therapeutics shares are trading lower after Truist Securities cut its price target on the stock from $11 to $10.

News

1 day ago · seekingalpha.com

Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market

Autolus Therapeutics plc is a UK-based biotech that has brought its ex-vivo CAR-T cell therapy to market in B-ALL with a "best-in-class" safety/efficacy profile. In this small indication, peak revenue...

2 weeks ago · seekingalpha.com

I Missed The Quantum Rally - I Won't Miss The Next One

Here's the next batch of weird science stocks that have market darling potential. I'm tracking five meme-worthy, deep science sectors: brain-computer interfaces, CRISPR/gene editing, organoids, progra...

3 weeks ago · seekingalpha.com

Autolus Therapeutics plc (AUTL) Q1 2025 Earnings Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Amanda Cray – Executive Director-Investor Relations Christian Itin – Chief Executiv...

2 months ago · seekingalpha.com

Autolus Therapeutics plc (AUTL) Q4 2024 Earnings Conference Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL ) Q4 2024 Earnings Conference Call March 20, 2025 8:30 AM ET Company Participants Amanda Cray - IR Christian Itin - CEO Rob Dolski - CFO Conference Call Participa...